Research Article
Treatment of Glucocorticoid-Induced Osteoporosis and Risk Factors for New Vertebral Fractures in Female Patients with Autoimmune Diseases
Table 2
Osteoporosis treatment for patients identified as high-risk for glucocorticoid-induced osteoporosis.
| ā | Prescribed no. (%) |
| Osteoporosis treatment | 56 (93) | Bisphosphonates | 30 (50) | With active vitamin D3 | 15 (25) | Without active vitamin D3 | 15 (25) | Teriparatide | 3 (5) | Denosumab with vitamin D3 | 12 (20) | Active vitamin D3 monotherapy | 11 (18) | Alfacalcidol | 7 (12) | Eldecalcitol | 4 (6) | Untreated | 4 (6) |
|
|